These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 12937655)

  • 1. HIV-1 NCp7 as a target for the design of novel antiviral agents.
    Druillennec S; Roques BP
    Drug News Perspect; 2000 Aug; 13(6):337-49. PubMed ID: 12937655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the mechanism of inactivation of the HIV-1 nucleocapsid protein NCp7 with 2-mercaptobenzamide thioesters.
    Jenkins LM; Byrd JC; Hara T; Srivastava P; Mazur SJ; Stahl SJ; Inman JK; Appella E; Omichinski JG; Legault P
    J Med Chem; 2005 Apr; 48(8):2847-58. PubMed ID: 15828823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mimic of HIV-1 nucleocapsid protein impairs reverse transcription and displays antiviral activity.
    Druillennec S; Dong CZ; Escaich S; Gresh N; Bousseau A; Roques BP; Fournié-Zaluski MC
    Proc Natl Acad Sci U S A; 1999 Apr; 96(9):4886-91. PubMed ID: 10220388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ordered aggregation of ribonucleic acids by the human immunodeficiency virus type 1 nucleocapsid protein.
    Stoylov SP; Vuilleumier C; Stoylova E; De Rocquigny H; Roques BP; Gérard D; Mély Y
    Biopolymers; 1997 Mar; 41(3):301-12. PubMed ID: 9057495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The single-finger nucleocapsid protein of moloney murine leukemia virus binds and destabilizes the TAR sequences of HIV-1 but does not promote efficiently their annealing.
    Egelé C; Piémont E; Didier P; Ficheux D; Roques B; Darlix JL; de Rocquigny H; Mély Y
    Biochemistry; 2007 Dec; 46(50):14650-62. PubMed ID: 18027912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The RNA recognition mechanism of human immunodeficiency virus (HIV) type 2 NCp8 is different from that of HIV-1 NCp7.
    Matsui T; Tanaka T; Endoh H; Sato K; Tanaka H; Miyauchi E; Kawashima Y; Nagai-Makabe M; Komatsu H; Kohno T; Maeda T; Kodera Y
    Biochemistry; 2009 May; 48(20):4314-23. PubMed ID: 19334676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptidomimetic therapeutic agents targeting the protease enzyme of the human immunodeficiency virus and hepatitis C virus.
    Tsantrizos YS
    Acc Chem Res; 2008 Oct; 41(10):1252-63. PubMed ID: 18681464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transmission electron microscopy reveals an optimal HIV-1 nucleocapsid aggregation with single-stranded nucleic acids and the mature HIV-1 nucleocapsid protein.
    Mirambeau G; Lyonnais S; Coulaud D; Hameau L; Lafosse S; Jeusset J; Justome A; Delain E; Gorelick RJ; Le Cam E
    J Mol Biol; 2006 Dec; 364(3):496-511. PubMed ID: 17020765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the structure of the top half of HIV-1 cTAR DNA on the nucleic acid destabilizing activity of the nucleocapsid protein NCp7.
    Beltz H; Piémont E; Schaub E; Ficheux D; Roques B; Darlix JL; Mély Y
    J Mol Biol; 2004 May; 338(4):711-23. PubMed ID: 15099739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of capsid sequence and immature nucleocapsid proteins p9 and p15 in Human Immunodeficiency Virus type 1 genomic RNA dimerization.
    Kafaie J; Dolatshahi M; Ajamian L; Song R; Mouland AJ; Rouiller I; Laughrea M
    Virology; 2009 Mar; 385(1):233-44. PubMed ID: 19070880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization and structural analysis of HIV-1 integrase conservation.
    Ceccherini-Silberstein F; Malet I; D'Arrigo R; Antinori A; Marcelin AG; Perno CF
    AIDS Rev; 2009; 11(1):17-29. PubMed ID: 19290031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification by high throughput screening of small compounds inhibiting the nucleic acid destabilization activity of the HIV-1 nucleocapsid protein.
    Shvadchak V; Sanglier S; Rocle S; Villa P; Haiech J; Hibert M; Van Dorsselaer A; Mély Y; de Rocquigny H
    Biochimie; 2009 Jul; 91(7):916-23. PubMed ID: 19401213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure of the His44 --> Ala single point mutant of the distal finger motif of HIV-1 nucleocapsid protein: a combined NMR, molecular dynamics simulation, and fluorescence study.
    Stote RH; Kellenberger E; Muller H; Bombarda E; Roques BP; Kieffer B; Mély Y
    Biochemistry; 2004 Jun; 43(24):7687-97. PubMed ID: 15196011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific targeting highly conserved residues in the HIV-1 reverse transcriptase primer grip region. Design, synthesis, and biological evaluation of novel, potent, and broad spectrum NNRTIs with antiviral activity.
    Fattorusso C; Gemma S; Butini S; Huleatt P; Catalanotti B; Persico M; De Angelis M; Fiorini I; Nacci V; Ramunno A; Rodriquez M; Greco G; Novellino E; Bergamini A; Marini S; Coletta M; Maga G; Spadari S; Campiani G
    J Med Chem; 2005 Nov; 48(23):7153-65. PubMed ID: 16279773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucosidase inhibitors as antiviral agents for hepatitis B and C.
    Durantel D; Alotte C; Zoulim F
    Curr Opin Investig Drugs; 2007 Feb; 8(2):125-9. PubMed ID: 17328228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro characterization of a simian immunodeficiency virus-human immunodeficiency virus (HIV) chimera expressing HIV type 1 reverse transcriptase to study antiviral resistance in pigtail macaques.
    Ambrose Z; Boltz V; Palmer S; Coffin JM; Hughes SH; Kewalramani VN
    J Virol; 2004 Dec; 78(24):13553-61. PubMed ID: 15564466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal structures for HIV-1 reverse transcriptase in complexes with three pyridinone derivatives: a new class of non-nucleoside inhibitors effective against a broad range of drug-resistant strains.
    Himmel DM; Das K; Clark AD; Hughes SH; Benjahad A; Oumouch S; Guillemont J; Coupa S; Poncelet A; Csoka I; Meyer C; Andries K; Nguyen CH; Grierson DS; Arnold E
    J Med Chem; 2005 Dec; 48(24):7582-91. PubMed ID: 16302798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on HIV resistance and resistance testing.
    Sebastian J; Faruki H
    Med Res Rev; 2004 Jan; 24(1):115-25. PubMed ID: 14595674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human immunodeficiency virus type-1 accessory protein Vpr: a causative agent of the AIDS-related insulin resistance/lipodystrophy syndrome?
    Kino T; Chrousos GP
    Ann N Y Acad Sci; 2004 Jun; 1024():153-67. PubMed ID: 15265780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.